Research & Development

七七久久在线色七七影院久久成人影院第二季度奥利奥卖得不错 归功于新兴市场增长


  阿嬌笑道︰“您的馬車可還好使?”   即便是餓著肚子,匈奴人也想著漢地的糧食跟美麗的女人。七七久久在线   “說的好听,爾諸子百家遁深山,絕溝壑,人不出山卻讓天下輿論紛紛,閑暇之時派遣一二弟子禍亂天下以為樂事。朕以為,亂天下者就是你諸子百家,與爾等相比,神仙之事雖然渺茫,卻無傷大雅。”色七七影院   甦稚破涕為笑,胡亂擦拭一下臉上的淚水道︰“要不然我以後也跟紅袖一樣伺候你好不好?”   “師兄,小妹問你,人的血真的分甲乙丙丁四種樣子嗎?”久久成人影院   “啊?這麼有用的學問你為何不知道?你都在山門里學了些什麼?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo